| Cash flows from operating activities: | |
| Net income | 193.67M |
| Adjustments to reconcile net income to net cash (used in) provided by operating activities: | |
| Depreciation and amortization | 195.02M |
| Recognition of deferred grant proceeds | |
| Amortization of loss on hedge arrangement | |
| Amortization of debt issuance costs and discount | |
| Recognition of stock-based compensation expense | |
| Deferred income taxes | |
| Restructuring and impairment charges | |
| Provision for allowance for doubtful accounts and notes receivable | |
| Excess tax benefit from options exercised | |
| Loss on sale of property | |
| Loss on disposal of subsidiaries | |
| Change in operating assets and liabilities, exclusive of net assets acquired: | |
| Trade accounts receivable | -172.16M |
| Inventories | -222.65M |
| Prepaid expenses and other current assets | -6.35M |
| Other assets | -2.8M |
| Accounts payable and accrued expenses | 288M |
| Income taxes payable | -9.09M |
| Net cash (used in) provided by operating activities | 305.68M |
| Cash flows from investing activities: | |
| Acquisition of property, plant and equipment | -371.47M |
| Proceeds from sale of property, plant and equipment | 9.5M |
| Cost of receivables acquired, net of cash collections | |
| Proceeds on disposal of available for sale investments | |
| Net cash (used in) investing activities | -370.77M |
| Cash flows from financing activities: | |
| Borrowings under debt agreements | |
| Payments toward debt agreements | |
| Net proceeds from exercise of stock options and issuance of common stock under employee stock purchase plan | 10.87M |
| Treasury stock minimum tax withholding related to vesting of restricted stock | -129.26M |
| Dividends paid to stockholders | -34.75M |
| Bond issuance costs | |
| Bank overdraft of subsidiary | |
| Excess tax benefit from options exercised | 330K |
| Net cash provided by (used in) financing activities | -85.74M |
| Effect of exchange rate changes on cash and cash equivalents | -4.77M |
| Net decrease in cash and cash equivalents | -155.6M |
| Cash and cash equivalents at beginning of period | 1.22B |
| Cash and cash equivalents at end of period | 1.06B |